• T Labbe
Hematology
CLC Bio
Denmark
Biography
Prior to founding SpePharm in 2006, Jean-François Labbé was an investor in and Chief Executive Officer of OTL Pharma, a Paris-based specialty pharmaceutical and orphan drug company, which achieved €14M sales in 2004, the year he sold the business to Strakan (now ProStrakan). Prior to founding SpePharm in 2006, Jean-François Labbé was an investor in and Chief Executive Officer of OTL Pharma, a Paris-based specialty pharmaceutical and orphan drug company, which achieved €14M sales in 2004, the year he sold the business to Strakan (now ProStrakan).
Research Interest
Orphan drug, Pharma
